NIH Funding Opportunities and Notices for May 02, 2014

Dear Colleagues:

NIH has released clarification on eligibility for K awards (in NOT-OD-14-08) and updated information on reporting for Non-Competing Type 5 Progress Reports (NOT-OD-14-085).   A summary of both is below.  Please read, and redistribute broadly to relevant faculty and researchers in your area.

Thank you!


Greg Ruth
Communications Manager

Office of Research

 

 

From: Jeffrey Warner <Jeffrey.Warner@UCOP.EDU>
Date: May 2, 2014 at 4:26:38 PM PDT
To: UCRAO-L@LISTSERV.UCOP.EDU
Subject: NIH Funding Opportunities and Notices for May 02, 2014
Reply-To: Jeffrey Warner <Jeffrey.Warner@UCOP.EDU>

Dear Colleagues,

 

NOT-OD-14-08 – Notice of Clarification of Career (K) Award Eligibility

 

Currently reads:


Foreign Institutions
Foreign components, as defined in the NIH Grants Policy Statement (included below), are not allowed.

 

Modified to read:


Foreign Institutions
Foreign components, as defined in the NIH Grants Policy Statement (included below), are allowed.


All other aspects of these FOAs remain the same.

 

This clarification pertains to all applications submitted in response to the following FOAs:

  • PA-14-044: Mentored Research Scientist Development Award (Parent K01)
  • PA-14-045: Independent Scientist Award (Parent K02)
  • PA-14-046: Mentored Clinical Scientist Research Career Development Award (Parent K08)
  • PA-14-049: Mentored Patient-Oriented Research Career Development Award (Parent K23)
  • PA-14-047: Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
  • PA-14-048: Mentored Quantitative Research Development Award (Parent K25)
  • PA-14-042: NIH Pathway to Independence Award (Parent K99/R00)

 

Foreign component – the performance of any significant scientific element or segment of a project outside of the United States, either by the grantee or by a researcher employed by a foreign organization, whether or not grant funds are expended. Foreign travel for consultation is not considered a foreign component. Activities that would meet this definition include, but are not limited to, (1) the involvement of human subjects or animals, (2) extensive foreign travel by grantee project staff for the purpose of data collection, surveying, sampling, and similar activities, or (3) any activity of the grantee that may have an impact on U.S. foreign policy through involvement in the affairs or environment of a foreign country. Examples of other grant-related activities that may be significant are:

 

          collaborations with investigators at a foreign site anticipated to result in co-authorship;

          use of facilities or instrumentation at a foreign site; or

          receipt of financial support or resources from a foreign entity.

 

 

NOT-OD-14-085 – Transition Plans for Reporting Sex/Gender, Race, and Ethnicity Information in Non-Competing Type 5 Progress Reports

 

The purpose of this NIH Guide Notice is to notify grantees of changes related to reporting sex/gender, race, and ethnicity information when conducting NIH-defined clinical research.  On October 16, 2014, the NIH will transition to a new module within the eRA Commons (known as the Inclusion Management System, or IMS) used for reporting sex/gender, race, and ethnicity information as required by the NIH Policy on the Inclusion of Women and Minorities in Clinical Research (see NOT-OD-14-086). The previous system (known as the Population Tracking System) will be retired this summer.  

 

The NIH is also transitioning to an updated format for reporting sex/gender, race, and ethnicity information.  As noted in NOT-OD-13-092, the NIH has modified the format used to report sex/gender, race, and ethnicity information of individuals enrolled in clinical research studies.  Applicants submitting competing applications have been using the updated formats starting with receipt dates on or after September 25, 2013.

It is now time to transition to the modified format for Type 5 non-competing progress report submissions using the PHS 2590 or the RPPR (Research Performance Progress Report) as we prepare to deploy the Inclusion Management System.

 

Awards with start dates BEFORE October 1, 2014 must use the previous inclusion enrollment reporting format:

 

          When submitting a progress report before July 18, continue to use the link in the RPPR that brings you to the current Pop Tacking system.

          When submitting a progress report after July 18, the link will take you to a PDF of the previous inclusion report format that you will attach to section G.4.b of the RPPR.

          If using the PHS2590, use the PDF version of the previous inclusion enrollment reporting format.

 

Awards with start dates AFTER October 1, 2014 must use the updated inclusion enrollment format:

 

          When submitting a progress report between July 18, 2014 and October 16, 2014 grantees will be directed to upload a PDF of the updated inclusion enrollment reporting format in section G.4.b of the RPPR rather than access a link to a structured data form.

          Once the Inclusion Management System is available on October 17, 2014, grantees submitting non-competing Type 5 progress reports using the RPPR will have access to a link to the Inclusion Management System in Section G.4.b of the RPPR that will allow reporting of the inclusion enrollment data using the updated reporting format.  

          If using the PHS2590, use the PDF version of the updated inclusion enrollment reporting format. – See more at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-085.html#sthash.bMuB8Oj0.dpuf

 

 

Regards,

 

Jeff Warner

Research Policy Analyst
Research Policy Analysis and Coordination

University of California, Office of the President

1111 Franklin St. 11th Floor, 11210C

Oakland, CA 94607

Jeffrey.Warner@ucop.edu

510-987-0076

 

 

Scroll to Top